Found: 65
Select item for more details and to access through your institution.
Administration of Latent Membrane Protein 2–Specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus–Positive Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 4, p. 342
- By:
- Publication type:
- Article
Survivin-specific T cell receptor targets tumor but not T cells.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 1, p. 157, doi. 10.1172/JCI75876
- By:
- Publication type:
- Article
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Gene Marking and Autologous Bone Marrow Transplantationa.
- Published in:
- Annals of the New York Academy of Sciences, 1994, v. 716, n. 1, p. 204, doi. 10.1111/j.1749-6632.1994.tb21713.x
- By:
- Publication type:
- Article
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221107113
- By:
- Publication type:
- Article
A backpack revs up T-cell activity.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 702, doi. 10.1038/nbt.4215
- By:
- Publication type:
- Article
Engineered off-the-shelf therapeutic T cells resist host immune rejection.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 1, p. 56, doi. 10.1038/s41587-020-0601-5
- By:
- Publication type:
- Article
A backpack revs up T-cell activity.
- Published in:
- Nature Biotechnology, 2018, v. 36, n. 8, p. 702, doi. 10.1038/nbt.4215
- By:
- Publication type:
- Article
An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies.
- Published in:
- Stem Cells, 2010, v. 28, n. 6, p. 1107, doi. 10.1002/stem.433
- By:
- Publication type:
- Article
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
- Published in:
- Nature Medicine, 2008, v. 14, n. 11, p. 1264, doi. 10.1038/nm.1882
- By:
- Publication type:
- Article
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.
- Published in:
- Nature Medicine, 2006, v. 12, n. 10, p. 1160, doi. 10.1038/nm1475
- By:
- Publication type:
- Article
Time to optimize vaccination strategies in blood cancer patients.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 406, doi. 10.1111/bjh.19598
- By:
- Publication type:
- Article
Moving CAR‐Ts to the outpatient clinic.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 507, doi. 10.1111/bjh.19129
- By:
- Publication type:
- Article
Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 6, p. e84, doi. 10.1111/bjh.16370
- By:
- Publication type:
- Article
T‐cell receptor sequencing demonstrates persistence of virus‐specific T cells after antiviral immunotherapy.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 2, p. 206, doi. 10.1111/bjh.16053
- By:
- Publication type:
- Article
Recent advances in T-cell immunotherapy for haematological malignancies.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 688, doi. 10.1111/bjh.14470
- By:
- Publication type:
- Article
Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.
- Published in:
- Journal of Clinical Apheresis, 1999, v. 14, n. 3, p. 154, doi. 10.1002/(SICI)1098-1101(1999)14:3<154::AID-JCA9>3.0.CO;2-K
- By:
- Publication type:
- Article
Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0020267
- By:
- Publication type:
- Article
Complement-Fixing CD45 Monoclonal Antibodies to Facilitate Stem Cell Transplantation in Mouse and Man.
- Published in:
- Annals of the New York Academy of Sciences, 2003, v. 996, n. 1, p. 80, doi. 10.1111/j.1749-6632.2003.tb03236.x
- By:
- Publication type:
- Article
Immunotherapy for Epstein-Barr virus-associated cancers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1998, v. 90, n. 9, p. 89
- By:
- Publication type:
- Article
The Use of Chimeric Antigen Receptor T Cells in Patients With Non-Hodgkin Lymphoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 5, p. 375
- By:
- Publication type:
- Article
Graft Versus Leukemia Response Without Graft-versus-host Disease Elicited By Adoptively Transferred Multivirus-specific T-cells.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 1, p. 179, doi. 10.1038/mt.2014.192
- By:
- Publication type:
- Article
Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 6, p. 1211, doi. 10.1038/mt.2014.47
- By:
- Publication type:
- Article
Systemic Inflammatory Response Syndrome After Administration of Unmodified T Lymphocytes.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 6, p. 1134, doi. 10.1038/mt.2014.48
- By:
- Publication type:
- Article
Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 3, p. 623, doi. 10.1038/mt.2013.262
- By:
- Publication type:
- Article
Combining Drugs and Biologics to Treat Nasopharyngeal Cancer.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 8, doi. 10.1038/mt.2013.272
- By:
- Publication type:
- Article
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2087, doi. 10.1038/mt.2013.185
- By:
- Publication type:
- Article
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 11, p. 2113, doi. 10.1038/mt.2013.151
- By:
- Publication type:
- Article
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 8, p. 1622, doi. 10.1038/mt.2012.130
- By:
- Publication type:
- Article
Antiviral T-cell therapy.
- Published in:
- Immunological Reviews, 2014, v. 258, n. 1, p. 12, doi. 10.1111/imr.12138
- By:
- Publication type:
- Article
T lymphocytes targeting native receptors.
- Published in:
- Immunological Reviews, 2014, v. 257, n. 1, p. 39, doi. 10.1111/imr.12133
- By:
- Publication type:
- Article
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.
- Published in:
- Cancer Gene Therapy, 2004, v. 11, n. 2, p. 81, doi. 10.1038/sj.cgt.7700664
- By:
- Publication type:
- Article
Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma.
- Published in:
- International Journal of Cancer, 2001, v. 93, n. 5, p. 706, doi. 10.1002/ijc.1396
- By:
- Publication type:
- Article
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 285, p. 1, doi. 10.1126/scitranslmed.aaa2546
- By:
- Publication type:
- Article
Antigen-specific T cell therapies for cancer.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 20, p. R67, doi. 10.1093/hmg/ddv270
- By:
- Publication type:
- Article
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 242, p. 1, doi. 10.1126/scitranslmed.3008825
- By:
- Publication type:
- Article
Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 12, p. 2258, doi. 10.1038/mt.2011.167
- By:
- Publication type:
- Article
CARs on Track in the Clinic.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
Safer CARS.
- Published in:
- 2010
- By:
- Publication type:
- Editorial
Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1779, doi. 10.1038/mt.2009.133
- By:
- Publication type:
- Article
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 9, p. 1616, doi. 10.1038/mt.2009.140
- By:
- Publication type:
- Article
Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 5, p. 880, doi. 10.1038/mt.2009.34
- By:
- Publication type:
- Article
The Clone Ranger?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
766. Immunotherapy for Her2-Positive Medulloblastoma: Regression of Experimental Tumors by Transfer of Her2-Redirected T Cells In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S296, doi. 10.1016/j.ymthe.2006.08.851
- By:
- Publication type:
- Article
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
- Published in:
- Molecular Therapy, 2005, v. 12, n. 5, p. 933, doi. 10.1016/j.ymthe.2005.04.016
- By:
- Publication type:
- Article
1074. The Use of Genetically Modified Antigen Presenting Cells to Generate Donor-Derived Virus-Specific Cytotoxic T Lymphocytes Reactive Against CMV and Adenoviral Antigens for Clinical Use
- Published in:
- 2005
- By:
- Publication type:
- Abstract
795. The Use of Autologous LMP2-Specific Cytotoxic T Lymphocytes for the Treatment of Relapsed EBV +ve Hodgkin Disease and Non-Hodgkin Lymphoma
- Published in:
- 2005
- By:
- Publication type:
- Abstract